ImmunityBio Inc. (IBRX)
2.84
-0.45 (-13.68%)
At close: Mar 03, 2025, 3:59 PM
2.91
2.46%
After-hours: Mar 03, 2025, 04:38 PM EST
ImmunityBio Revenue
ImmunityBio reported an annual revenue of $622K, reflecting a 159.17% growth. For the quarter ending September 30, 2024, ImmunityBio generated $6.11M in revenue.
Revenue (ttm)
$622K
Revenue Growth
159.17%
Price / Sales Ratio
4105.07
Revenue / Employee
$925.6
Employees
672
Market Cap
2.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 622K | +159.17% |
| Dec 31, 2022 | 240K | -74.30% |
| Dec 31, 2021 | 934K | +54.38% |
| Dec 31, 2020 | 605K | n/a |